Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

Selective activity of 2,4-diaryl-1,2,3,4-tetrahydroquinolines on Trypanosoma cruzi epimastigotes and amastigotes expressing β-galactosidase.

Fonseca-Berzal C, Merchán Arenas DR, Romero Bohórquez AR, Escario JA, Kouznetsov VV, Gómez-Barrio A.

Bioorg Med Chem Lett. 2013 Sep 1;23(17):4851-6. doi: 10.1016/j.bmcl.2013.06.079. Epub 2013 Jul 12.

PMID:
23899616
2.

In vitro phenotypic screening of 7-chloro-4-amino(oxy)quinoline derivatives as putative anti-Trypanosoma cruzi agents.

Fonseca-Berzal C, Rojas Ruiz FA, Escario JA, Kouznetsov VV, Gómez-Barrio A.

Bioorg Med Chem Lett. 2014 Feb 15;24(4):1209-13. doi: 10.1016/j.bmcl.2013.12.071. Epub 2014 Jan 9.

PMID:
24461296
3.

Novel solid dispersions of benznidazole: preparation, dissolution profile and biological evaluation as alternative antichagasic drug delivery system.

Fonseca-Berzal C, Palmeiro-Roldán R, Escario JA, Torrado S, Arán VJ, Torrado-Santiago S, Gómez-Barrio A.

Exp Parasitol. 2015 Feb;149:84-91. doi: 10.1016/j.exppara.2015.01.002. Epub 2015 Jan 9.

PMID:
25583295
4.

Selective activity of polyene macrolides produced by genetically modified Streptomyces on Trypanosoma cruzi.

Rolón M, Seco EM, Vega C, Nogal JJ, Escario JA, Gómez-Barrio A, Malpartida F.

Int J Antimicrob Agents. 2006 Aug;28(2):104-9. Epub 2006 Jul 17.

PMID:
16844353
5.

New Imidazole-Based Compounds Active Against Trypanosoma cruzi.

Adeyemi OS, Molina MT, Eseola AO, Fonseca-Berzal C, Gómez-Barrio A.

Comb Chem High Throughput Screen. 2017;20(1):20-24. doi: 10.2174/1386207320666170110141907.

PMID:
28071587
6.

In vitro activity of N-benzenesulfonylbenzotriazole on Trypanosoma cruzi epimastigote and trypomastigote forms.

Becerra MC, Guiñazú N, Hergert LY, Pellegrini A, Mazzieri MR, Gea S, Albesa I.

Exp Parasitol. 2012 May;131(1):57-62. doi: 10.1016/j.exppara.2012.02.028. Epub 2012 Mar 8.

PMID:
22425748
7.

Trypanocidal effect of the benzyl ester of N-propyl oxamate: a bi-potential prodrug for the treatment of experimental Chagas disease.

Wong-Baeza C, Nogueda-Torres B, Serna M, Meza-Toledo S, Baeza I, Wong C.

BMC Pharmacol Toxicol. 2015 Apr 22;16:10. doi: 10.1186/s40360-015-0010-4.

8.

In vitro and in vivo trypanocidal activity of the ethyl esters of N-allyl and N-propyl oxamates using different Trypanosoma cruzi strains.

Aguirre-Alvarado C, Zaragoza-Martínez F, Rodríguez-Páez L, Nogueda B, Baeza I, Wong C.

J Enzyme Inhib Med Chem. 2007 Apr;22(2):227-33.

PMID:
17518350
9.

Biological characterization of a beta-galactosidase expressing clone of Trypanosoma cruzi CL strain.

Le-Senne A, Muelas-Serrano S, Fernández-Portillo C, Escario JA, Gómez-Barrio A.

Mem Inst Oswaldo Cruz. 2002 Dec;97(8):1101-5. Epub 2003 Jan 20.

10.

Complexation of the anti-Trypanosoma cruzi drug benznidazole improves solubility and efficacy.

Nogueira Silva JJ, Pavanelli WR, Gutierrez FR, Alves Lima FC, Ferreira da Silva AB, Santana Silva J, Wagner Franco D.

J Med Chem. 2008 Jul 24;51(14):4104-14. doi: 10.1021/jm701306r. Epub 2008 Jun 21.

PMID:
18570370
11.

Toxic effects of natural piperine and its derivatives on epimastigotes and amastigotes of Trypanosoma cruzi.

Ribeiro TS, Freire-de-Lima L, Previato JO, Mendonça-Previato L, Heise N, de Lima ME.

Bioorg Med Chem Lett. 2004 Jul 5;14(13):3555-8.

PMID:
15177472
12.

A quinoxaline derivative as a potent chemotherapeutic agent, alone or in combination with benznidazole, against Trypanosoma cruzi.

Rodrigues JH, Ueda-Nakamura T, Corrêa AG, Sangi DP, Nakamura CV.

PLoS One. 2014 Jan 17;9(1):e85706. doi: 10.1371/journal.pone.0085706. eCollection 2014.

13.

Further insights into biological evaluation of new anti-Trypanosoma cruzi 5-nitroindazoles.

Fonseca-Berzal C, Escario JA, Arán VJ, Gómez-Barrio A.

Parasitol Res. 2014 Mar;113(3):1049-56. doi: 10.1007/s00436-013-3740-5. Epub 2014 Jan 17.

PMID:
24435615
14.

Chelating agent inhibition of Trypanosoma cruzi epimastigotes in vitro.

Rodrigues RR, Lane JE, Carter CE, Bogitsh BJ, Singh PK, Zimmerman LJ, Molenda JJ, Jones MM.

J Inorg Biochem. 1995 Dec;60(4):277-88.

PMID:
8530923
15.

Novel polymorphs of the anti-Trypanosoma cruzi drug benznidazole.

Honorato SB, Mendonça JS, Boechat N, Oliveira AC, Mendes Filho J, Ellena J, Ayala AP.

Spectrochim Acta A Mol Biomol Spectrosc. 2014 Jan 24;118:389-94. doi: 10.1016/j.saa.2013.08.096. Epub 2013 Sep 5.

PMID:
24076454
16.

The efficacy of novel arylimidamides against Trypanosoma cruzi in vitro.

DA Silva CF, Daliry A, DA Silva PB, Akay S, Banerjee M, Farahat AA, Fisher MK, Hu L, Kumar A, Liu Z, Stephens CE, Boykin DW, Correia Soeiro MD.

Parasitology. 2011 Dec;138(14):1863-9. doi: 10.1017/S0031182011001429. Epub 2011 Sep 9.

PMID:
21902869
17.

In vitro and in vivo studies of the antiparasitic activity of sterol 14α-demethylase (CYP51) inhibitor VNI against drug-resistant strains of Trypanosoma cruzi.

Soeiro Mde N, de Souza EM, da Silva CF, Batista Dda G, Batista MM, Pavão BP, Araújo JS, Aiub CA, da Silva PB, Lionel J, Britto C, Kim K, Sulikowski G, Hargrove TY, Waterman MR, Lepesheva GI.

Antimicrob Agents Chemother. 2013 Sep;57(9):4151-63. doi: 10.1128/AAC.00070-13. Epub 2013 Jun 17.

18.
19.

In vitro and in vivo trypanocidal effects of the cyclopalladated compound 7a, a drug candidate for treatment of Chagas' disease.

Matsuo AL, Silva LS, Torrecilhas AC, Pascoalino BS, Ramos TC, Rodrigues EG, Schenkman S, Caires AC, Travassos LR.

Antimicrob Agents Chemother. 2010 Aug;54(8):3318-25. doi: 10.1128/AAC.00323-10. Epub 2010 May 17.

20.

Trypanocidal activity of 4 isopropyl salicylaldehyde and 4-isopropyl salicylic acid on Trypanosoma cruzi.

Nogueda-Torres B, Rodríguez-Paez L, Ramírez IB, Ramírez CW.

Rev Latinoam Microbiol. 2001 Jan-Mar;43(1):1-6.

PMID:
17061565

Supplemental Content

Support Center